Catalyst Pharmaceuticals Inc

-0.19 (-2.69%)
Earnings Announcements

Catalyst Pharmaceuticals Reports Q3 2021 Financial Results

Published: 11/09/2021 22:42 GMT
Catalyst Pharmaceuticals Inc (CPRX) - Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results.
Q3 Non-GAAP Earnings per Share $0.14 Excluding Items.
Q3 GAAP Earnings per Share $0.10.
Q3 Revenue Rose 6.7 Percent to $35.9 Million.
Q3 Earnings per Share View $0.10, Revenue View $34.6 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $36.9 Million
Adjusted EPS is expected to be $0.11

Next Quarter Revenue Guidance is expected to be $38.26 Million
Next Quarter EPS Guidance is expected to be $0.11

More details on our Analysts Page.